Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124746523 | 12474652 | 3 | F | 20160608 | 20160630 | 20160617 | 20160705 | EXP | HU-ROCHE-1777594 | ROCHE | 71.00 | YR | M | Y | 0.00000 | 20160705 | MD | HU | HU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124746523 | 12474652 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intrathecal | Y | 103705 | 25 | MG | 1X | |||||||
| 124746523 | 12474652 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | ||||||||||
| 124746523 | 12474652 | 3 | SS | IDARUBICIN | IDARUBICIN | 1 | Intravenous (not otherwise specified) | 0 | 20 | MG | |||||||||
| 124746523 | 12474652 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intravenous (not otherwise specified) | 0 | 3000 | MG | 1X | ||||||||
| 124746523 | 12474652 | 5 | SS | ARA-C | CYTARABINE | 1 | Intravenous (not otherwise specified) | 0 | 1000 | MG | |||||||||
| 124746523 | 12474652 | 6 | C | SUPRASTIN | CHLOROPYRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 20 | MG | 1X | ||||||||
| 124746523 | 12474652 | 7 | C | APRANAX | NAPROXEN | 1 | Oral | 0 | 550 | MG | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124746523 | 12474652 | 1 | Diffuse large B-cell lymphoma |
| 124746523 | 12474652 | 2 | Diffuse large B-cell lymphoma |
| 124746523 | 12474652 | 3 | Diffuse large B-cell lymphoma |
| 124746523 | 12474652 | 4 | Diffuse large B-cell lymphoma |
| 124746523 | 12474652 | 5 | Diffuse large B-cell lymphoma |
| 124746523 | 12474652 | 6 | Premedication |
| 124746523 | 12474652 | 7 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124746523 | 12474652 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124746523 | 12474652 | Off label use | |
| 124746523 | 12474652 | Radiculopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124746523 | 12474652 | 1 | 20160608 | 20160608 | 0 | |
| 124746523 | 12474652 | 3 | 20160608 | 0 | ||
| 124746523 | 12474652 | 4 | 20160608 | 0 | ||
| 124746523 | 12474652 | 5 | 20160608 | 0 | ||
| 124746523 | 12474652 | 6 | 20160608 | 20160608 | 0 | |
| 124746523 | 12474652 | 7 | 20160608 | 20160608 | 0 |